82 related articles for article (PubMed ID: 36281595)
1. [Ⅰ. Recent Trends in Chemotherapy followed by Surgery for Patients with Locally Advanced Biliary-Pancreatic Cancer].
Takano S; Kuboki S; Takayashiki T; Suzuki D; Sakai N; Hosokawa I; Mishima T; Konishi T; Nishino H; Nakada S; Miyazaki M; Ohtsuka M
Gan To Kagaku Ryoho; 2022 Oct; 49(10):1054-1058. PubMed ID: 36281595
[No Abstract] [Full Text] [Related]
2. [Chemoradiotherapy for locally recurrence after primary resection of biliary-pancreatic cancer].
Maemura K; Shinchi H; Noma H; Mataki Y; Kurahara H; Maeda S; Natsugoe S; Takao S
Gan To Kagaku Ryoho; 2009 Feb; 36(2):265-8. PubMed ID: 19223743
[TBL] [Abstract][Full Text] [Related]
3. Response to doxorubicin/methotrexate/fluorouracil in advanced adenocarcinoma of pancreas or biliary tract.
Pyrhönen S; Valtonen M
Lancet; 1990 Jul; 336(8707):127. PubMed ID: 1975317
[No Abstract] [Full Text] [Related]
4. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
[TBL] [Abstract][Full Text] [Related]
5. FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience.
Moretto R; Raimondo L; De Stefano A; Cella CA; Matano E; De Placido S; Carlomagno C
Anticancer Drugs; 2013 Oct; 24(9):980-5. PubMed ID: 23928570
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer.
Glimelius B; Hoffman K; Sjödén PO; Jacobsson G; Sellström H; Enander LK; Linné T; Svensson C
Ann Oncol; 1996 Aug; 7(6):593-600. PubMed ID: 8879373
[TBL] [Abstract][Full Text] [Related]
7. 5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors.
Abad A; Rosell R; Barnadas A; Carles J; Ribelles N; Solano V
Ann Oncol; 1991 Feb; 2(2):153. PubMed ID: 2054318
[No Abstract] [Full Text] [Related]
8. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of resminostat, an HDAC inhibitor, combined with S-1 in patients with pre-treated biliary tract or pancreatic cancer.
Ikeda M; Ohno I; Ueno H; Mitsunaga S; Hashimoto Y; Okusaka T; Kondo S; Sasaki M; Sakamoto Y; Takahashi H; Hara R; Kobayashi S; Nakamura O; Morizane C
Invest New Drugs; 2019 Feb; 37(1):109-117. PubMed ID: 29995287
[TBL] [Abstract][Full Text] [Related]
10. A new in-vitro drug sensitivity test (collagen-gel droplet embedded-culture drug sensitivity test) in carcinomas of pancreas and biliary tract: possible clinical utility.
Yasuda H; Takada T; Wada K; Amano H; Isaka T; Yoshida M; Uchida T; Toyota N
J Hepatobiliary Pancreat Surg; 1998; 5(3):261-8. PubMed ID: 9880773
[TBL] [Abstract][Full Text] [Related]
11. A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.
LoConte NK; Holen KD; Schelman WR; Mulkerin DL; Deming DA; Hernan HR; Traynor AM; Goggins T; Groteluschen D; Oettel K; Robinson E; Lubner SJ
Invest New Drugs; 2013 Aug; 31(4):943-8. PubMed ID: 23263993
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas.
Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T
Oncology; 1994; 51(5):396-400. PubMed ID: 8052479
[TBL] [Abstract][Full Text] [Related]
13. Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers.
Pino MS; Milella M; Gelibter A; Sperduti I; De Marco S; Nuzzo C; Bria E; Carpanese L; Ruggeri EM; Carlini P; Cognetti F
Oncology; 2009; 76(4):254-61. PubMed ID: 19246950
[TBL] [Abstract][Full Text] [Related]
14. [The development of chemotherapy to unresectable advanced biliary tract cancer].
Arima S; Naruge D; Kasuga A; Kitamura H; Takasu M; Nagashima F; Furuse J
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1490-3. PubMed ID: 23133874
[No Abstract] [Full Text] [Related]
15. Rhabdomyosarcoma of extrahepatic biliary tree: initial treatment with chemotherapy and conservative surgery.
Pollono DG; Tomarchio S; Berghoff R; Drut R; Urrutia A; Cédola J
Med Pediatr Oncol; 1998 May; 30(5):290-3. PubMed ID: 9544225
[TBL] [Abstract][Full Text] [Related]
16. Continuous hepatic arterial infusion chemotherapy for liver metastasis from biliary tract and pancreatic cancers.
Kato Y; Tsuyuki A; Kikuchi K; Tokuyama J; Kurihara N; Kumamoto Y; Fujishiro Y; Ebinuma H
Anticancer Res; 2005; 25(1B):477-82. PubMed ID: 15816615
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy Improves Survival After Percutaneous Biliary Drainage in Patients With Pancreatic or Biliary Tract Cancer With Biliary Obstruction.
Niemelä J; Syrjälä H; Ohtonen P; Saarnio J; Kallio R
Anticancer Res; 2021 Jun; 41(6):2979-2984. PubMed ID: 34083288
[TBL] [Abstract][Full Text] [Related]
18. Gallbladder and biliary tract carcinoma: A comprehensive update, Part 1.
Rajagopalan V; Daines WP; Grossbard ML; Kozuch P
Oncology (Williston Park); 2004 Jun; 18(7):889-96. PubMed ID: 15255172
[TBL] [Abstract][Full Text] [Related]
19. Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery.
Donahue TR; Isacoff WH; Hines OJ; Tomlinson JS; Farrell JJ; Bhat YM; Garon E; Clerkin B; Reber HA
Arch Surg; 2011 Jul; 146(7):836-43. PubMed ID: 21768431
[TBL] [Abstract][Full Text] [Related]
20. BRCA-associated pancreatico-biliary neoplasms: Four cases illustrating the emerging clinical impact of genotyping.
Sharma MB; Carus A; Sunde L; Hamilton-Dutoit S; Ladekarl M
Acta Oncol; 2016; 55(3):377-81. PubMed ID: 26004055
[No Abstract] [Full Text] [Related]
[Next] [New Search]
